Back
Monte Rosa Therapeutics Vs. Kyndryl Holdings Industry Stock Comparison
Buy
55
GLUE
Monte Rosa Therapeutics
Last Price:
8.49
Seasonality Move:
7.5%
Sell
22
KD
Kyndryl Holdings
Last Price:
33.07
Seasonality Move:
21.65%
Buy
55
Monte Rosa Therapeutics (GLUE)
is a Buy
Is Monte Rosa Therapeutics a Buy, Sell or Hold?
- The current Monte Rosa Therapeutics [GLUE] share price is $8.49. The Score for GLUE is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- GLUE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Kyndryl Holdings (KD)
is a Sell
Is Kyndryl Holdings a Buy, Sell or Hold?
- The current Kyndryl Holdings [KD] share price is $33.05. The Score for KD is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- KD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GLUE Stock Price Chart
What is Monte Rosa Therapeutics's stock price today?
-
The Monte Rosa Therapeutics share price today is $8.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLUE is experiencing slight buying pressure.
KD Stock Price Chart
What is Kyndryl Holdings's stock price today?
-
The Kyndryl Holdings share price today is $33.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KD is experiencing slight selling pressure.
GLUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 56.06 | Buy |
| Chaikin Money Flow: | 60229 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.48 - 9.7) | Buy |
| Bollinger Bands (100): | (4.14 - 7.54) | Buy |
KD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.81 | Buy |
| Relative Strength Index (14 RSI): | 84.9 | Buy |
| Chaikin Money Flow: | -44447 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.34 - 29.08) | Buy |
| Bollinger Bands (100): | (22.56 - 26.92) | Buy |
GLUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.24 | Buy |
| 20-day SMA: | 8.85 | Sell |
| 50-day SMA: | 6.76 | Buy |
| 200-day SMA: | 5.65 | Buy |
| 8-day EMA: | 8.4 | Buy |
| 20-day EMA: | 8.17 | Buy |
| 50-day EMA: | 7.19 | Buy |
| 200-day EMA: | 5.91 | Buy |
KD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.38 | Buy |
| 20-day SMA: | 26.71 | Buy |
| 50-day SMA: | 24.99 | Buy |
| 200-day SMA: | 24.01 | Buy |
| 8-day EMA: | 29.79 | Buy |
| 20-day EMA: | 27.67 | Buy |
| 50-day EMA: | 25.83 | Buy |
| 200-day EMA: | 23.56 | Buy |
Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.
Kyndryl Holdings Earnings Growth & KD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.26 per share.
Monte Rosa Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kyndryl Holdings Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||